Personalizing Medication Management with Pharmacogenetic Testing (PGT) in Mental Health

Variability in medication response among patients being treated for mental health disorders is a well-known challenge for clinicians, often leading to multiple medication trials to find the regimen which is effective without intolerable side effects. PGT helps clinicians move beyond trial and error to make more effective prescribing decisions that are personalized for each patient. Focusing on case studies in mental health, this program will demonstrate how a patient’s genetic profile may impact his or her response to certain medications.


Title: Personalizing Medication Management with Pharmacogenetic Testing (PGT) in Mental Health
Date: Thursday, February 16, 2017
Time: 10:00 AM Pacific Daylight Time
Duration: 1 hour, 1 minute
Objectives: Upon completion of this session participants will be able to:

  • Explain how genetic variability may influence medication efficacy and toxicity
  • Discuss how genetic variations may allow clinicians to more effectively understand medication response
  • Understand how PGT may provide valuable, objective information for more personalized therapy in mental health


Adam Rzetelny, Ph.D.

Dr. Rzetelny is a licensed clinical psychologist and Associate Director of Clinical Affairs at Millennium Health. He has more than 15 years of experience as a researcher, clinician, and educator in areas including addiction, psychiatry, and pain. He has treated severe mental illness in hospital settings and authored peer-reviewed publications and chapters on topics including clinical drug testing, and pharmacogenetics. Dr. Rzetelny has lectured extensively around the nation and supervised a federally funded lab investigating pharmacogenetics of nicotine dependence at Southern Illinois University at Carbondale. His post-doctoral training at Memorial Sloan Kettering Cancer Center in New York exposed him to clinical cases at the cross roads of cancer pain and addiction.

Register to view the webinar